Skip to main content
. 2021 Dec 6;2021:7522487. doi: 10.1155/2021/7522487

Table 2.

Comparison of anthropometric, clinical, hormonal, metabolic, and biochemical parameters in dominant genotype model for INSR rs1799817 SNP in PCOS women.

Parameter PCOS P value Controls P value
CC + CT (n = 230) TT (n = 19) CC + CT (n = 88) TT (n = 12)
Age (years) 22.48 ± 4.19 21.88 ± 3.64 0.54 22.03 ± 3.15 21.83 ± 3.46 0.83
Weight (kg) 59.86 ± 11.71 61.53 ± 11.18 0.54 51.64 ± 6.61 54.17 ± 7.37 0.22
Height (m) 1.57 ± 0.05 1.55 ± 0.04 0.09 1.56 ± 0.05 1.58 ± 0.07 0.21
BMI (kg/m2) 24.23 ± 4.74 25.55 ± 4.37 0.24 21.08 ± 2.42 21.75 ± 2.89 0.38
Waist (cm) 83.17 ± 11.25 82.76 ± 10.74 0.87 76.59 ± 6.68 80.08 ± 9.47 0.11
Hip (cm) 93.39 ± 8.37 95.00 ± 7.57 0.48 90.82 ± 5.88 94.83 ± 8.46 0.03
WHR 0.89 ± 0.08 0.88 ± 0.07 0.59 0.84 ± 0.05 0.84 ± 0.06 1.00
WHtR 0.53 ± 0.07 0.53 ± 0.07 1.00 0.49 ± 0.04 0.51 ± 0.06 0.13
BAI 29.44 ± 4.78 31.18 ± 3.68 0.12 28.46 ± 3.01 29.80 ± 3.13 0.15
SBP (mmHg) 120.88 ± 7.45 118.41 ± 8.12 0.16 118.59 ± 5.49 121.67 ± 3.89 0.06
DBP (mmHg) 80.86 ± 5.87 80.65 ± 6.38 0.88 79.01 ± 5.34 81.58 ± 3.70 0.11
Menarche (yr) 13.14 ± 1.14 12.88 ± 1.17 0.34 13.30 ± 1.11 13.17 ± 0.83 0.69
FG score 13.99 ± 6.60 15.71 ± 6.59 0.27 4.59 ± 1.79 4.08 ± 2.23 0.37
LH (IU/L) 11.36 ± 9.82 10.15 ± 5.15 0.59 6.74 ± 2.37 6.00 ± 2.19 0.30
FSH (IU/L) 6.15 ± 1.85 5.77 ± 2.08 0.39 6.91 ± 1.99 6.83 ± 1.94 0.89
TT (ng/dL) 60.62 ± 21.28 72.31 ± 38.94 0.03 33.85 ± 15.06 36.32 ± 19.75 0.60
SHBG (nmol/L) 50.20 ± 21.75 49.31 ± 21.69 0.86 66.13 ± 25.51 55.97 ± 23.89 0.19
Andro (ng/mL) 3.26 ± 0.87 3.16 ± 0.79 0.62 2.22 ± 0.69 2.52 ± 0.62 0.15
DHEAS (ng/mL) 3.79 ± 1.16 3.74 ± 1.08 0.85 2.78 ± 1.29 3.83 ± 1.02 0.00
Insulin (μIU/ml) 13.29 ± 6.88 15.29 ± 7.94 0.23 7.52 ± 4.78 9.17 ± 8.88 0.32
Glu F (mg/dL) 85.60 ± 8.51 88.35 ± 10.01 0.18 84.17 ± 8.97 87.25 ± 7.88 0.26
Glu 2 h (mg/dL) 114.72 ± 18.08 122.18 ± 18.89 0.08 108.23 ± 12.83 110.92 ± 23.00 0.54
Chol (mg/dL) 154.80 ± 35.04 156.00 ± 31.43 0.88 133.58 ± 19.14 146.33 ± 17.29 0.03
TG (mg/dL) 120.78 ± 35.62 119.88 ± 38.82 0.91 102.76 ± 14.54 102.50 ± 17.13 0.95
HOMA-IR 2.85 ± 1.62 3.71 ± 1.92 0.02 1.56 ± 1.01 2.04 ± 2.03 0.18
QUICKI 0.33 ± 0.02 0.32 ± 0.02 0.03 0.37 ± 0.04 0.39 ± 0.08 0.16
FAI 5.76 ± 5.72 6.33 ± 4.30 0.67 2.17 ± 1.70 2.53 ± 1.33 0.48
LH:FSH 1.88 ± 1.22 1.84 ± 1.09 0.89 1.05 ± 0.57 0.91 ± 0.29 0.40
LAP 35.51 ± 21.74 35.43 ± 22.71 0.98 21.69 ± 8.52 25.94 ± 12.29 0.12
Urea 22.63 ± 6.09 23.88 ± 5.19 0.38 21.34 ± 3.58 21.12 ± 2.62 0.83
Cre (mg/dL) 1.04 ± 0.43 0.85 ± 0.20 0.05 0.81 ± 0.14 0.78 ± 0.12 0.48
AST (U/L) 31.24 ± 12.40 36.12 ± 13.12 0.10 18.36 ± 8.20 17.85 ± 4.67 0.83
ALT (U/L) 28.23 ± 14.18 23.18 ± 7.11 0.12 23.22 ± 6.85 25.21 ± 6.29 0.34

Data presented as mean ± SD. P value <0.05 significant. P values calculated by independent Student's t test. PCOS: polycystic ovary syndrome, BMI: body mass index, SBP: systolic blood pressure, DBP: diastolic blood pressure, men: menarche, FG score: Ferriman–Gallwey score, LH: luteinizing hormone, FSH: follicle-stimulating hormone, TT: total testosterone, PRL: prolactin, TSH: thyroid-stimulating hormone, SHBG: sex hormone-binding globin, andro: androstenedione, DHEAS: dehydroepiandrosterone sulfate, Glu F: glucose fasting, CHOL: cholesterol, TG: triglycerides, HOMA: IR homeostasis model assessment-estimated insulin resistance, QUICKI: quantitative insulin sensitivity check index, FAI: free androgen index, UA: uric acid, Cre: creatinine, AST: aspartate aminotransferase, and ALT: alanine aminotransferase.